| Schedule of Weighted Average Dilutive Common Shares Anti-Dilutive |
The
common stock equivalents associated with the following securities are excluded from the calculation of weighted average dilutive common
shares because their inclusion would have been anti-dilutive:
Schedule of Weighted Average Dilutive Common Shares Anti-Dilutive
| | |
June 30, | |
| | |
2022 | | |
2021 | |
| | |
| | |
| |
| Options | |
| 6,182,004 | | |
| 6,182,004 | |
| Warrants | |
| 12,284,079 | | |
| 9,946,388 | |
| Convertible notes [1] [2] | |
| 1,951,241 | | |
| 1,760,041 | |
| Convertible preferred stock | |
| 18,123,043 | | |
| 13,421,950 | |
| Total | |
| 38,540,367 | | |
| 31,310,383 | |
| [1] |
Convertible
notes are assumed to be converted at the rate of $0.75 per common share, which is the conversion
price as of June 30, 2022 and 2021. However, such conversion rates are subject to adjustment under certain circumstances, which may
result in the issuance of common shares greater than the amount indicated. |
| |
|
| [2] |
Excludes
shares of common stock underlying convertible notes that are expected to become convertible into shares of Series B Convertible Preferred
Stock since such stock had not been designated by the Company as of June 30, 2022 and 2021. |
|